Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
ABBV-438 in Relapse multiple myeloma: NCT07409246 Clinical Landscape Report 2026
28 September 2026
NCT07409246 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SENL-103 in Relapse multiple myeloma: NCT07421856 Clinical Landscape Report 2026
28 September 2026
NCT07421856 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ziftomenib in IDH1 Mutation Acute Myeloid Leukemia: NCT07411586 Clinical Landscape Report 2026
28 September 2026
NCT07411586 clinical landscape for IDH1 Mutation Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Luteolin in Asteatotic eczema: TCTR20260220001 Clinical Landscape Report 2026
28 September 2026
TCTR20260220001 clinical landscape for Asteatotic eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cladribine in Acute Myeloid Leukemia: NCT07423104 Clinical Landscape Report 2026
28 September 2026
NCT07423104 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CNSI-Fe in Lung Cancer: NCT07433283 Clinical Landscape Report 2026
28 September 2026
NCT07433283 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zimberelimab in Squamous cell carcinoma of vulva: NCT07424664 Clinical Landscape Report 2026
28 September 2026
NCT07424664 clinical landscape for Squamous cell carcinoma of vulva: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Venetoclax in Adult Acute Myeloblastic Leukemia: NCT07425782 Clinical Landscape Report 2026
28 September 2026
NCT07425782 clinical landscape for Adult Acute Myeloblastic Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Apremilast in Pruritus: NCT07432386 Clinical Landscape Report 2026
28 September 2026
NCT07432386 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Escitalopram Oxalate in Depressive Disorder: NCT07432815 Clinical Landscape Report 2026
28 September 2026
NCT07432815 clinical landscape for Depressive Disorder: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Universal CLL1 CAR-T cells(Tianjin First Central Hospital) in Relapsing acute myeloid leukemia: NCT07432100 Clinical Landscape Report 2026
28 September 2026
NCT07432100 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Eganelisib in Acute Myeloid Leukemia: NCT07439211 Clinical Landscape Report 2026
28 September 2026
NCT07439211 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.